A study on the link between spotted wing drosophila populations, crop damage, and yield losses
Annabelle Firlej
Researcher, Ph.D.
450 653-7368
ext 363
Description
There is very little documentation on the link between the number of spotted wing drosophila captured in traps and berry crop damage and associated economic losses. The aim of this project was to gather the necessary data to determine whether trap captures can predict damage levels and yield losses in the field. Traps were installed for two years in five raspberry fields in Québec. Numbers of adults in the traps and larva in the fruit, as well as yield losses and the percentage of undamaged fruit were evaluated every week during the harvest season.
Objective(s)
- Determine where there is a significant correlation between the number of adult spotted wing drosophila captured and yield losses observed in the field
- Demonstrate that the risk of damage (larva in the fruit) is low when the number of adults in the traps is low.
From 2015 to 2017
Project duration
Fruit production
Activity areas
Pest, weed, and disease control, Organic farming
Services
IRDA boasts considerable expertise in the fight against new invasive insects.
Partner
Ministère de l'Agriculture, des Pêcheries et de l'Alimentation du Québec - Prime-vert Programme
This may interest you
A new molecular approach to simultaneously detect disease-causing viruses in raspberries and strawberries
Developing a fast and sensitive molecular detection methodology able to accurately identify raspberry and strawberry viruses.
Researchers: Richard Hogue Luc Belzile
Attract and kill strategies for control of the plum curculio in conventional and organic apple orchards
An attract and kill technique to control plum curculio was recently proposed by U.S. researchers, but it is very little used in orchards and virtually unknown in Québec.
Researcher: Gérald Chouinard
Tailoring apple scab control strategies to the properties of the fungicides utilized
Developing a new scab control strategy based on selecting the lowest-risk products that best fit the circumstances at hand, and tailoring the doses accordingly.
Researcher: Vincent Philion
